Comparison of BCG vaccination at birth and at third month of life

dc.contributor.authorÇavuşoğlu, Bülent
dc.contributor.buuauthorIldırım, İbrahim
dc.contributor.buuauthorSapan, Nihat
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı.tr_TR
dc.date.accessioned2021-06-21T08:12:04Z
dc.date.available2021-06-21T08:12:04Z
dc.date.issued1992-08-28
dc.description.abstractTuberculosis is an important health problem in developing countries and the BCG vaccine plays an important part in preventing the disease. There are different reports about the preventive value of BCG. Some of them claim that it is satisfactory while others suggest that it provides little protection. There are also varying ideas about the optimum time to vaccinate babies, some studies suggesting that late vaccination confers a high degree of protection. This prospective controlled study has been undertaken to evaluate the value of BCG vaccine given to babies during their first three days of life versus its value when given in their third month of life. Evaluation was measured by the results of tests with purified protein derivative (PPD), by vaccine scars, and by the complications of the vaccine. It was found that BCG given at the end of the third month provides a higher rate of response and fewer complications than when given during the first three days of life.en_US
dc.identifier.citationIldırım, İ. vd. (1992). ''Comparison of BCG vaccination at birth and at third month of life''. Archives of Disease in Childhood, 67(1), 50-82.en_US
dc.identifier.endpage82
dc.identifier.issn0003-9888
dc.identifier.issue1
dc.identifier.pubmed1739343
dc.identifier.startpage80
dc.identifier.urihttps://doi.org/10.1136/adc.67.1.80
dc.identifier.urihttps://adc.bmj.com/content/archdischild/67/1/80.full.pdf
dc.identifier.urihttp://hdl.handle.net/11452/20671
dc.identifier.volume67
dc.identifier.wosA1992HA93000003
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherBritish Medical Journal Publication Groupen_US
dc.relation.journalArchives of Disease in Childhooden_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectTuberculosisen_US
dc.subject.emtreeBCG vaccineen_US
dc.subject.emtreeTuberculinen_US
dc.subject.emtreeAgeen_US
dc.subject.emtreeBCG vaccinationen_US
dc.subject.emtreeComparative studyen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDrug efficacyen_US
dc.subject.emtreeDrug safetyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman experimenten_US
dc.subject.emtreeInfanten_US
dc.subject.emtreeIntradermal drug administrationen_US
dc.subject.emtreeNewbornen_US
dc.subject.emtreeNormal humanen_US
dc.subject.emtreeProspective studyen_US
dc.subject.emtreeTuberculosisen_US
dc.subject.wosPediatricsen_US
dc.titleComparison of BCG vaccination at birth and at third month of lifeen_US
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
80.full.pdf
Size:
451.23 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: